FAIRFIELD, N.J., June 15, 2012 /PRNewswire/ -- Aperture Health,
Inc. (OTC APRE) is intending to capitalize on the strength of
management's experience in the coordination of care at home and
the direct provision of hi-tech disease specific pharmacy
services in the alternate care setting. Management believes
that Jim Hennig's 30 years of
experience in the pharmacy industry, including 10 years building,
directing and managing physician partnered pharmacy
enterprises will provide confidence to the market in Aperture's
ability to penetrate and provide exceptional service offerings into
the growing long term disease management arena.
James Hennig, R.Ph., Chief
Executive Officer and Chairman of the Board of Directors commented,
"With the increasing focus being placed on alternate site
therapeutics, in particular the home, we are highly confident in
our ability to expand our IV therapy service capabilities by
combining hi-tech nursing, clinical pharmacy, and medication
management services coupled with streamlined communication to all
medical providers involved in the patient's care. We can play an
integral part in the hyper growth of disease specific medical
management in today's healthcare environment."
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad
Therapeutics operates a fully JCAHO accredited home IV therapy
company, achieving this "gold standard" status in 2007. The company
has built a well respected reputation in its industry for its
therapy expertise and commitment to care for its patient clients.
The company services clients throughout the States of New Jersey, New
York and Connecticut,
providing opportunity for organic growth. Triad's full time
marketing and sales personnel continuously represent the company in
the core services areas, growing and maintaining the company's
referral source base. Patient referrals are made from physicians,
hospitals, insurance companies, veterinarians and hospice care
providers that have established a professional rapport with
Triad
Safe Harbor
Certain statements in this news release are forward-looking,
including (without limitation) growing revenues and earnings,
expected results from current projects and attracting new
business. Undue reliance should not be placed on such
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties and other
unpredictable factors, many of which are beyond the Company's
control. The Company's actual results, performance and trends could
differ materially from those indicated or implied by such
statements as a result of various factors, including (without
limitation) the continued strengthening of Triad's selling and
marketing functions, continued customer satisfaction, contract
renewal, new product development, continued availability of capable
dedicated personnel, continued cost management, success and
availability of acquisitions, availability of financing and other
factors, as well as by factors applicable to most companies such as
general economic, competitive and other business and civil
conditions. Information regarding certain of those and other
risk factors and cautionary statements that could affect future
results, performance or trends is discussed in the Company's OTC
Disclosure Statement and unaudited management financials posted on
www.pinksheets.com . All of the Company's forward-looking
statements are expressly qualified by all such risk factors and
other cautionary statements. The information set forth herein
speaks only as of the date hereof.
SOURCE Aperture Health, Inc.